Related Experiment Video
Updated: Jun 16, 2026
06:09
A Three-Dimensional Digital Model for Early Diagnosis of Hepatic Fibrosis Based on Magnetic Resonance Elastography
Published on: July 21, 2023
[Mathematical models using conventional laboratory indicators to predict hepatic fibrosis progressing in chronic
Jing Chen1, Jia-Ji Jiang, Qi Zheng
1Liver Diseases Research Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, China. mykelchen@sina.com
Zhonghua Yi Xue Za Zhi
|January 26, 2010
Summary
This study developed mathematical models using common lab tests to predict liver fibrosis in chronic hepatitis B patients. These models effectively identify fibrosis progression and cirrhosis, aiding clinical diagnosis.
Area of Science:
- Hepatology and Gastroenterology
- Biostatistics and Mathematical Modeling
- Biochemical Diagnostics
Context:
- Chronic hepatitis B (CHB) poses a significant risk for liver fibrosis and cirrhosis.
- Accurate, non-invasive methods for assessing fibrosis progression are crucial for patient management.
- Conventional laboratory indicators offer a readily accessible resource for diagnostic modeling.
Purpose:
- To develop and validate mathematical models for diagnosing liver fibrosis progression in CHB patients.
- To evaluate the clinical utility of these models in predicting hepatic fibrosis and hepatocirrhosis.
- To identify key laboratory indicators predictive of fibrosis stages.
Summary:
- A cohort of 391 CHB patients underwent liver biopsy and routine laboratory tests.
- Multiple logistic regression identified platelet count (PLT), international normalized ratio (INR), albumin (ALB), gamma-glutamyltransferase (GGT), and cholinesterase (CHE) as independent predictors.
- Developed predictive models (Fibrosis Scores) demonstrated good performance via ROC curve analysis, with areas under the curve ranging from 0.768 to 0.806.
Impact:
- The established mathematical models provide a valuable, non-invasive tool for predicting liver fibrosis progression in CHB.
- These models can aid clinicians in early diagnosis and timely intervention, potentially improving patient outcomes.
- Highlights the utility of routine laboratory tests in developing sophisticated diagnostic algorithms for liver disease.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
A recent model describes pravastatin's hepatobiliary excretion, mediated...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...